Agenus (AGEN) Cash & Equivalents (2010 - 2026)
Agenus' Cash & Equivalents came in at $18.74 million for Q2 2026, up 96.5% from $9.53 million a year earlier but down 46.5% from the prior quarter.
Powered by 
Analysis
Agenus (AGEN) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Agenus' Cash & Equivalents was $3 million, down 92.6% from FY2024.
- Cash & Equivalents has declined in each of the last four years, with a five-year compound annual growth rate of -50.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $40.44 million in FY2024 (-46.9%), $76.11 million in FY2023 (-57.4%), $178.67 million in FY2022 (-38.8%) and $291.93 million in FY2021 (+192.3%).
- The five-year range for quarterly Cash & Equivalents is $3 million (Q4 2025) to $291.93 million (Q4 2021).
- Year-over-year, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 32.3%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2022 (growth of 210.5%), and the weakest in Q4 2025 (a decline of 92.6%).
- Business Quant data shows AGEN's Cash & Equivalents at $35 million (Q1 2026), $3 million (Q4 2025) and $3.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Agenus | 356.27 Mn | 349.49 Mn | 34.52 Mn | 18.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.74 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 9.53 Mn |
| Mar 31, 2025 | 18.49 Mn |
| Dec 31, 2024 | 40.44 Mn |
| Sep 30, 2024 | 44.78 Mn |
| Jun 30, 2024 | 93.72 Mn |
| Mar 31, 2024 | 52.86 Mn |
| Dec 31, 2023 | 76.11 Mn |
| Sep 30, 2023 | 106.31 Mn |
| Jun 30, 2023 | 143.21 Mn |
| Mar 31, 2023 | 164.82 Mn |
| Dec 31, 2022 | 178.67 Mn |
| Sep 30, 2022 | 208.35 Mn |
| Jun 30, 2022 | 228.39 Mn |
| Mar 31, 2022 | 247.71 Mn |
| Dec 31, 2021 | 291.93 Mn |
| Sep 30, 2021 | 256.53 Mn |
API Access
Agenus Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();